T 2524/12 (Anti-ERBB antibody cancer therapy/GENENTECH) of 11.07.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T252412.20160711
- Date of decision
- 11 July 2016
- Case number
- T 2524/12
- Petition for review of
- -
- Application number
- 01939145.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
- Applicant name
- Genentech, Inc.
- Opponent name
- BioGeneriX AG
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Withdrawal of approval of text on which patent was granted - appeal dismissed
- Catchword
- -
Order
For these reasons it is decided that:
The appeal is dismissed.